The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis
Abstract Introduction: Currently, none of the available multiple sclerosis (MS) disease-modifying medications has been shown to stop or reverse gait…
Edoardo Sessa
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)
Abstract Background: The approval of Sativex for the management of multiple sclerosis (MS) spasticity opened a new opportunity to many…
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
Abstract Nabiximols (Sativex) is an oromucosal spray, containing delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD), used as treatment for unresponsive spasticity…
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
Abstract Sativex is an emergent treatment option for spasticity in patients affected by multiple sclerosis (MS). This oromucosal spray, acting…